{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:36:45Z","timestamp":1772577405161,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2020.01.062","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T17:42:04Z","timestamp":1580924524000},"page":"2350-2360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-0636","authenticated-orcid":false,"given":"Shabir A.","family":"Madhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthonet","family":"Koen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"van Niekerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"de Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8250-8307","authenticated-orcid":false,"given":"Clare L.","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Schoonbroodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ruiz-Gui\u00f1az\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Yarzabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Borys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.062_b0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.01.062_b0010","unstructured":"World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper \u2013 February 2019. Available at: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/310968\/WER9408.pdf?ua=1. Last accessed: 29 March 2019."},{"key":"10.1016\/j.vaccine.2020.01.062_b0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.prrv.2011.12.001","article-title":"Streptococcus pneumoniae-a review of carriage, infection, serotype replacement and vaccination","volume":"13","author":"Mehr","year":"2012","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.vaccine.2020.01.062_b0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.01.062_b0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.062_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085459","article-title":"Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1\u20134 years: a randomized controlled trial","volume":"9","author":"Hammitt","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.062_b0035","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2010.12.086","article-title":"Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage","volume":"29","author":"Prymula","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.062_b0040","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial","volume":"56","author":"van den Bergh","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.062_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jpids\/piw010","article-title":"Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland","volume":"5","author":"Vesikari","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2020.01.062_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1287640","article-title":"Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children \u2013 a randomized controlled trial","volume":"13","author":"S\u00e1ez-Llorens","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.01.062_b0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(15)70007-1","article-title":"Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial","volume":"15","author":"Hamaluba","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.062_b0060","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.vaccine.2017.03.071","article-title":"Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: a phase 2, randomized, controlled, observer-blind study","volume":"35","author":"Odutola","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.062_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001839","article-title":"The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity in high-income countries","volume":"12","author":"Flasche","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2020.01.062_b0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(14)70139-0","article-title":"Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial","volume":"2","author":"Palmu","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2020.01.062_b0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2020.01.062_b0080","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1016\/j.vaccine.2012.05.055","article-title":"Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy","volume":"30","author":"Madhi","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.01.062_b0085","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.vaccine.2010.02.029","article-title":"The National Advisory Group on Immunization (NAGI) of the Republic of South Africa","volume":"28","author":"Schoub","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.062_b0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005881","article-title":"Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status","volume":"96","author":"Madhi","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2020.01.062_b0095","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14760584.2017.1321990","article-title":"Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial","volume":"16","author":"Madhi","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.01.062_b0100","unstructured":"World Health Organization. Case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/HIVstaging150307.pdf?ua=1. Last accessed: 29 March 2019."},{"key":"10.1016\/j.vaccine.2020.01.062_b0105","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2015.04.024","article-title":"Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine","volume":"33","author":"Madhi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.062_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103293","article-title":"Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis","volume":"9","author":"Adegbola","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.062_b0115","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.vaccine.2014.12.023","article-title":"Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age","volume":"33","author":"Nunes","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.062_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085001","article-title":"Pneumococcal carriage in sub-Saharan Africa-a systematic review","volume":"9","author":"Usuf","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.062_b0125","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.01.062_b0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/aje\/kwx048","article-title":"Imputing the direct and indirect effectiveness of childhood pneumococcal conjugate vaccine against invasive pneumococcal disease by surveying temporal changes in nasopharyngeal pneumococcal colonization","volume":"186","author":"Nzenze","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.01.062_b0135","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1097\/INF.0000000000000084","article-title":"Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization","volume":"33","author":"Loo","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:39Z","timestamp":1759401639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20301006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X20301006"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}